Research Article
3D-QSAR Study of the Chalcone Derivatives as Anticancer Agents
| Descriptors | Q2 | R2 | N | F | SEE |
| Steric (S) | 0.637 | 0.943 | 3 | 55.27 | 0.068 | Electrostatic (E) | 0.543 | 0.901 | 3 | 56.98 | 0.090 | Hydrophobic (H) | 0.508 | 0.932 | 3 | 45.35 | 0.075 | H-bond donor (D) | 0.406 | 0.650 | 3 | 06.18 | 0.170 | H-bond acceptor (A) | 0.745 | 0.872 | 3 | 22.66 | 0.103 | EA | 0.724 | 0.898 | 3 | 29.29 | 0.092 | ED | 0.430 | 0.834 | 3 | 16.75 | 0.117 | EH | 0.487 | 0.907 | 3 | 32.64 | 0.087 | ES | 0.484 | 0.931 | 3 | 44.98 | 0.075 | SA | 0.833 | 0.919 | 3 | 37.57 | 0.082 | SD | 0.568 | 0.832 | 3 | 16.53 | 0.118 | SH | 0.584 | 0.958 | 3 | 75.26 | 0.059 | AH | 0.751 | 0.911 | 3 | 33.95 | 0.086 | AD | 0.637 | 0.832 | 3 | 16.86 | 0.117 | DH | 0.547 | 0.819 | 3 | 15.07 | 0.122 | SHE | 0.550 | 0.925 | 3 | 41.04 | 0.079 | SED | 0.501 | 0.881 | 3 | 24.65 | 0.099 | SEA | 0.779 | 0.916 | 3 | 36.19 | 0.083 | SHA | 0.806 | 0.934 | 3 | 47.29 | 0.074 | SHD | 0.601 | 0.868 | 3 | 21.85 | 0.104 | SAD | 0.645 | 0.873 | 3 | 22.88 | 0.102 | EAD | 0.608 | 0.879 | 3 | 24.11 | 0.100 | EAH | 0.742 | 0.913 | 3 | 34.86 | 0.080 | AHD | 0.679 | 0.872 | 3 | 22.73 | 0.103 | EDH | 0.533 | 0.871 | 3 | 22.45 | 0.103 | SEHD | 0.574 | 0.897 | 3 | 28.93 | 0.092 | SEHA | 0.773 | 0.928 | 3 | 42.72 | 0.077 | SHDA | 0.727 | 0.897 | 3 | 28.95 | 0.092 | EHDA | 0.653 | 0.886 | 3 | 25.93 | 0.079 | SEAD | 0.661 | 0.885 | 3 | 25.69 | 0.097 | SEHDA | 0.697 | 0.903 | 3 | 31.00 | 0.089 |
|
|